Molecular epidemiology of tuberculosis in a low- to moderate-incidence state: are contact investigations enough?

Wendy A Cronin, Jonathan E Golub, Monica J Lathan, Leonard N Mukasa, Nancy Hooper, Jafar H Razeq, Nancy G Baruch, Donna Mulcahy, William H Benjamin, Laurence S Magder, G Thomas Strickland, William R Bishai, Wendy A Cronin, Jonathan E Golub, Monica J Lathan, Leonard N Mukasa, Nancy Hooper, Jafar H Razeq, Nancy G Baruch, Donna Mulcahy, William H Benjamin, Laurence S Magder, G Thomas Strickland, William R Bishai

Abstract

To assess the circumstances of recent transmission of tuberculosis (TB) (progression to active disease <2 years after infection), we obtained DNA fingerprints for 1172 (99%) of 1179 Mycobacterium tuberculosis isolates collected from Maryland TB patients from 1996 to 2000. We also reviewed medical records and interviewed patients with genetically matching M. tuberculosis strains to identify epidemiologic links (cluster investigation). Traditional settings for transmission were defined as households or close relatives and friends; all other settings were considered nontraditional. Of 436 clustered patients, 115 had recently acquired TB. Cluster investigations were significantly more likely than contact investigations to identify patients who recently acquired TB in nontraditional settings (33/42 vs. 23/72, respectively; p<0.001). Transmission from a foreign-born person to a U.S.-born person was rare and occurred mainly in public settings. The time from symptom onset to diagnosis was twice as long for transmitters as for nontransmitters (16.8 vs. 8.5 weeks, respectively; p<0.01). Molecular epidemiologic studies showed that reducing diagnostic delays can prevent TB transmission in nontraditional settings, which elude contact investigations.

Figures

Figure
Figure
Actions needed to decrease recent tuberculosis transmission in various settings. Decreasing diagnostic delays can potentially eliminate large point source clusters and substantially reduce transmission in both traditional and nontraditional settings. CI, contact investigation.

References

    1. Dye C, Scheele S, Dolin P, Pathania MC. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA. 1999;282:677–86. 10.1001/jama.282.7.677
    1. Institute of Medicine. Ending neglect: the elimination of tuberculosis in the United States. Washington: National Academy Press; 2000.
    1. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Morb Mortal Wkly Rep. 2000;49(No. RR-6).
    1. Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiological methods. N Engl J Med. 1994;300:1710–6. 10.1056/NEJM199406163302403
    1. Small PM, Hopewell PC, Singhe SP, Paz A, Parsonnet J, Ruston DC, et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med. 1994;330:1703–9. 10.1056/NEJM199406163302402
    1. Barnes PF, Yang Z, Preston-Martin S, Pogoda JM, Jones BE, Otaya M, et al. Patterns of tuberculosis transmission in Central Los Angeles. JAMA. 1997;278:1159–63. 10.1001/jama.278.14.1159
    1. Braden CR, Templeton GL, Cave MD, Valway S, Onorato IM, Castro KG, et al. Interpretation of restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis. 1997;175:1446–52. 10.1086/516478
    1. Burman WJ, Reves RR, Hawkes AP. DNA fingerprinting with two probes decreases clustering of Mycobacterium tuberculosis. Am J Respir Crit Care Med. 1997;155:1140–6.
    1. Bishai WR, Graham NMH, Harrington S, Pope DS, Hooper N, Astemborski J, et al. Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. JAMA. 1998;280:1679–84. 10.1001/jama.280.19.1679
    1. Maryland Office for New Americans. Immigration to Maryland, then and now. New American. 2000;6:4–5.
    1. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2001. Atlanta: Department of Health and Human Services, 2002.
    1. van Embden JDA, Cave MD, Crawford JT, Dale JW, Eisenbach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31:406–9.
    1. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Sooligen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35:907–14.
    1. Das S, Chan SL, Allen BW, Mitchison DA, Lowrie DB. Application of DNA fingerprinting with IS986 [IS6110] to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during, and after short-course therapy. Tuber Lung Dis. 1993;74:47–51. 10.1016/0962-8479(93)90068-9
    1. Cave MD, Eisenbach KD, Templeton G, Salfinger M, Mazurek G, Bates JH, et al. Stability of DNA genotype pattern produced with IS6110 in strains of Mycobacterium tuberculosis. J Clin Microbiol. 1994;32:262–6.
    1. Braden CR, Templeton GL, Stead WW, Bates JH, Cave MD, Valway SE. Retrospective detection of laboratory cross-contamination of Mycobacterium tuberculosis cultures with use of DNA fingerprint analysis. Clin Infect Dis. 1997;24:35–40.
    1. Burman WJ, Reves RR. Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment. Clin Infect Dis. 2000;31:1390–5. 10.1086/317504
    1. Nardell E, McInnis B, Thomas B, Weidhaus S. Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med. 1986;315:1570–5.
    1. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med. 1999;341:1174–9. 10.1056/NEJM199910143411602
    1. Centers for Disease Control and Prevention. Tuberculosis information management system (TIMS) user’s guide; surveillance appendix I. Atlanta: Centers for Disease Control and Prevention; 1998.
    1. Cronin WA, Magder LS, Baruch NG, Strickland GT, Bishai WR. Source identification for pediatric tuberculosis cases in Maryland. In: Abstracts of the 7th Annual North American Regional Conference of the International Union Against Tuberculosis and Lung Disease; Vancouver, Canada: March 2002. Vancouver, BC: British Columbia Lung Association;2002.
    1. Cronin WA, Golub JE, Magder LS, Baruch NG, Lathan MJ, Mukasa LN, et al. Usefulness of spoligotyping for secondary typing of Mycobacterium tuberculosis isolates with low copy numbers of IS6110. J Clin Microbiol. 2001;39:3709–11. 10.1128/JCM.39.10.3709-3711.2001
    1. Michele TM, Cronin WA, Graham NHM, Dwyer DM, Pope DS, Harrington S, et al. Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope: identification by DNA fingerprinting. JAMA. 1997;278:1093–5. 10.1001/jama.278.13.1093
    1. Cronin WA, Lathan MJ, Benjamin WH. Unusually high rates of tuberculosis infection and disease among oyster fishery workers in a rural community [abstract]. Int J Tuberc Lung Dis. 1998;11:S281.
    1. Sterling TR, Stanley RL, Brubach GA, Madison A, Harrington S, Bishai WR, et al. HIV-related tuberculosis in a transgender network—Baltimore, Maryland, and New York City Area. JAMA. 2000;283:2515–6. 10.1001/jama.283.19.2515
    1. Bur S, Golub J, Armstrong J, Johnson B, Maltas G, Barker L, et al. Anatomy of a large community and jail tuberculosis outbreak investigation. In: Abstracts of the 98th American Thoracic Society International Conference; San Francisco, California, April 2001. New York: American Thoracic Society;2001.
    1. Golub JE, Cronin WA, Obasanjo OO, Coggin W, Moore K, Pope DS, et al. Transmission of Mycobacterium tuberculosis through casual contact with an infectious patient. Arch Intern Med. 2001;161:2254–8. 10.1001/archinte.161.18.2254
    1. Lathan M, Cronin W, Mukasa L, Hooper D, Benjamin W. Outbreak of tuberculosis at a hospital identified by DNA fingerprinting. In: Abstracts of the National Tuberculosis Genotyping and Surveillance Network Annual Meeting; San Francisco, California, July 1999. Atlanta: Centers for Disease Control and Prevention;1999.
    1. Sterling TR, Pope DS, Bishai WR, Harrington S, Gershon RR, Chaisson RE. Transmission of Mycobacterium tuberculosis from a cadaver to an embalmer. N Engl J Med. 2000;342:246–8. 10.1056/NEJM200001273420404
    1. Glynn JR, Vynnycky E, Fine PEM. Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. Am J Epidemiol. 1999;149:366–71.
    1. Murray M, Alland D. Methodological problems in the molecular epidemiology of tuberculosis. Am J Epidemiol. 2002;155:565–71. 10.1093/aje/155.6.565
    1. Murray M, Nardell E. Molecular epidemiology of tuberculosis: achievements and challenges to current knowledge. Bull World Health Organ. 2002;80:477–82.
    1. Hermans PWM, Messadi F, Guebrexabher H, van Sooligan D, Haas PEW, Heersman H, et al. Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. J Infect Dis. 1995;171:1504–13.
    1. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2000. Atlanta: Department of Health and Human Services; 2001.
    1. Chin DP, DeReimer K, Small PM, Ponce de Leon A, Steinhart R, Schecter GF, et al. Differences in contributing factors to tuberculosis incidence in US-born and foreign-born persons. Am J Respir Crit Care Med. 1998;158:1797–803.
    1. Jasmer RM, Ponce de Leon A, Hopewell PC, Alarcon RG, Moss AR, Paz EA, et al. Tuberculosis in Mexican-born persons in San Francisco: reactivation, acquired infection and transmission. Int J Tuberc Lung Dis. 1997;1:536–41.
    1. Etkind SC. Contact tracing. In: Reichman L, Hershfield E, editors. TB: a comprehensive international approach. New York: Marcel Dekker, Inc.; 1993. p. 275–89.
    1. Valway SE, Sanchez MPC, Shinnick TF, Orme I, Agerton T, Hoy D, et al. An outbreak of extensive transmission of a virulent strain of Mycobacterium tuberculosis. N Engl J Med. 1998;338:633–9. 10.1056/NEJM199803053381001
    1. Asch S, Leake B, Anderson R, Gelberg L. Why do symptomatic patients delay obtaining care for tuberculosis? Am J Respir Crit Care Med. 1998;157:1244–8.
    1. Mather P, Sacks L, Auten G, Sall R, Levy C, Gordin F. Delayed diagnosis of pulmonary TB in city hospitals. Arch Intern Med. 1994;154:306–10. 10.1001/archinte.154.3.306
    1. Chin DP, Crane CM, Diul MY, Sun SJ, Agraz R, Taylor RS, et al. Spread of Mycobacterium tuberculosis in a community implementing recommended elements of tuberculosis control. JAMA. 2000;283:2968–74. 10.1001/jama.283.22.2968
    1. Golub J, Bur S, Cronin W, Baruch N, Comstock G, Chaisson R. Patient and health care delays in the diagnosis of Maryland tuberculosis patients. In: Abstracts of the 7th Annual North American Regional Conference of the International Union Against Tuberculosis and Lung Disease; Vancouver, Canada: March 2002. Vancouver, BC: British Columbia Lung Association;2002.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi